211 related articles for article (PubMed ID: 21220554)
1. Effect of hevin deletion in mice and characterization in trabecular meshwork.
Kang MH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2187-93. PubMed ID: 21220554
[TBL] [Abstract][Full Text] [Related]
2. Central corneal thickness does not correlate with TonoLab-measured IOP in several mouse strains with single transgenic mutations of matricellular proteins.
Chatterjee A; Oh DJ; Kang MH; Rhee DJ
Exp Eye Res; 2013 Oct; 115():106-12. PubMed ID: 23806329
[TBL] [Abstract][Full Text] [Related]
3. Regulation of SPARC by transforming growth factor β2 in human trabecular meshwork.
Kang MH; Oh DJ; Kang JH; Rhee DJ
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2523-32. PubMed ID: 23513064
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SPARC in human trabecular meshwork increases intraocular pressure and alters extracellular matrix.
Oh DJ; Kang MH; Ooi YH; Choi KR; Sage EH; Rhee DJ
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3309-19. PubMed ID: 23599341
[TBL] [Abstract][Full Text] [Related]
5. TGF-β2-mediated ocular hypertension is attenuated in SPARC-null mice.
Swaminathan SS; Oh DJ; Kang MH; Shepard AR; Pang IH; Rhee DJ
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4084-97. PubMed ID: 24906856
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase regulates intraocular pressure, extracellular matrix, and cytoskeleton in trabecular meshwork.
Chatterjee A; Villarreal G; Oh DJ; Kang MH; Rhee DJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3127-39. PubMed ID: 24713487
[TBL] [Abstract][Full Text] [Related]
7. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
8. Secreted protein acidic and rich in cysteine (SPARC)-null mice exhibit more uniform outflow.
Swaminathan SS; Oh DJ; Kang MH; Ren R; Jin R; Gong H; Rhee DJ
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2035-47. PubMed ID: 23422826
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells.
Villarreal G; Chatterjee A; Oh SS; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1657-65. PubMed ID: 24474275
[TBL] [Abstract][Full Text] [Related]
10. The matricellular protein SPARC is expressed in human trabecular meshwork.
Rhee DJ; Fariss RN; Brekken R; Sage EH; Russell P
Exp Eye Res; 2003 Nov; 77(5):601-7. PubMed ID: 14550402
[TBL] [Abstract][Full Text] [Related]
11. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure.
Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
13. SPARC-null mice exhibit lower intraocular pressures.
Haddadin RI; Oh DJ; Kang MH; Filippopoulos T; Gupta M; Hart L; Sage EH; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3771-7. PubMed ID: 19168904
[TBL] [Abstract][Full Text] [Related]
14. Altered Anterior Segment Biometric Parameters in Mice Deficient in SPARC.
Ho H; Htoon HM; Yam GH; Toh LZ; Lwin NC; Chu S; Lee YS; Wong TT; Seet LF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):386-393. PubMed ID: 28122087
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.
Fuchshofer R; Stephan DA; Russell P; Tamm ER
Exp Eye Res; 2009 Jun; 88(6):1020-32. PubMed ID: 19450457
[TBL] [Abstract][Full Text] [Related]
16. Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2.
Medina-Ortiz WE; Belmares R; Neubauer S; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6779-88. PubMed ID: 24030464
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures.
Haddadin RI; Oh DJ; Kang MH; Villarreal G; Kang JH; Jin R; Gong H; Rhee DJ
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6708-17. PubMed ID: 22930728
[TBL] [Abstract][Full Text] [Related]
18. Effect of SPARC Suppression in Mice, Perfused Human Anterior Segments, and Trabecular Meshwork Cells.
MacDonald WW; Swaminathan SS; Heo JY; Castillejos A; Hsueh J; Liu BJ; Jo D; Du A; Lee H; Kang MH; Rhee DJ
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):8. PubMed ID: 35671048
[TBL] [Abstract][Full Text] [Related]
19. Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell.
Fan Y; Wei J; Guo L; Zhao S; Xu C; Sun H; Guo T
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):38. PubMed ID: 32821914
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
